Serum matrix metalloproteinase-3 (MMP-3) as a predictive marker for the long-term disability of rheumatoid arthritis patients in a prospective observational cohort IORRA.

被引：0
|
作者：
Shinozaki, Mikiko [1 ]
Inoue, Eisuke [1 ]
Iikuni, Noriko [1 ]
Hara, Masako [1 ]
Tomatsu, Taisuke [1 ]
Kamatani, Naoyuki [1 ]
Yamanaka, Hisashi [1 ]
机构：
[1] Tokyo Womens Med Univ, Inst Rheumatol, Tokyo, Japan
来源：
ARTHRITIS AND RHEUMATISM | 2006年 / 54卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S185 / S185
页数：1
相关论文
共 50 条
  • [31] MATRIX METALLOPROTEINASES-3 (MMP-3) SERUM LEVEL AND GENETIC POLYMORPHISMS ASSOCIATED WITH RHEUMATOID ARTHRITIS
    Al-Nuaimy, W. A.
    Salloom, D. F.
    INFEKTSIYA I IMMUNITET, 2024, 14 (02): : 365 - 370
  • [32] Relationship between matrix metalloproteinase-3 serum level and pulmonary artery systolic pressure in patients with rheumatoid arthritis
    Tetsuro Sugiura
    Mikio Kamioka
    Shigeo Yamanaka
    Taisuke Hisahara
    Yoko Hirakawa
    Yoshihisa Matsumura
    Heart and Vessels, 2018, 33 : 191 - 197
  • [33] Comment on 'Baseline serum level of matrix metalloproteinase-3 as a biomarker of progressive joint damage in rheumatoid arthritis patients'
    Zhao, Ming-Dong
    Yuan, Feng-Lai
    Li, Xia
    Xiong, Min
    Cai, Guo-Ping
    Xu, Ji
    Zhang, Xin-Chao
    Yin, Wang-Ping
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2017, 20 (11) : 1794 - 1794
  • [34] CLINICAL SIGNIFICANCE OF SERUM MATRIX METALLOPROTEINASE-3 NORMALISATION IN RHEUMATOID ARTHRITIS PATIENTS WITH ANTI-TNF THERAPY
    Hattori, Y.
    Kaneko, A.
    Kida, D.
    Takahashi, N.
    Ishikawa, H.
    Kanda, H.
    Sato, T.
    Kojima, T.
    Ishiguro, N.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 487 - 488
  • [35] Steroid therapy and renal dysfunction are independently associated with serum levels of matrix metalloproteinase-3 in patients with rheumatoid arthritis
    Hattori, Yosuke
    Kida, Daihei
    Kaneko, Atsushi
    MODERN RHEUMATOLOGY, 2018, 28 (02) : 242 - 248
  • [36] Relationship between matrix metalloproteinase-3 serum level and pulmonary artery systolic pressure in patients with rheumatoid arthritis
    Sugiura, Tetsuro
    Kamioka, Mikio
    Yamanaka, Shigeo
    Hisahara, Taisuke
    Hirakawa, Yoko
    Matsumura, Yoshihisa
    HEART AND VESSELS, 2018, 33 (02) : 191 - 197
  • [37] Serum levels of matrix metalloproteinase-3 predict radiological damage of joints in rheumatoid arthritis.
    Suzuki, M
    Lee, T
    Tsukeoka, T
    Tsuneizumi, Y
    Masuda, K
    Masuda, R
    Kitahara, H
    Moriya, H
    ARTHRITIS AND RHEUMATISM, 2002, 46 (09): : S524 - S524
  • [38] Erratum to: Continuously elevated serum matrix metalloproteinase-3 for 3 ~ 6 months predict one-year radiographic progression in rheumatoid arthritis: a prospective cohort study
    Jian-Da Ma
    Xiu-Ning Wei
    Dong-Hui Zheng
    Ying-Qian Mo
    Le-Feng Chen
    Xiang Zhang
    Jin-Hua Li
    Lie Dai
    Arthritis Research & Therapy, 17
  • [39] Possible involvement of matrix metalloproteinase-3 in the pathogenesis of macroprolactinaemia in some patients with rheumatoid arthritis
    Adachi, Takashi
    Hattori, Naoki
    Ishihara, Takashi
    Iida, Hirokazu
    Saito, Takanori
    Miyashima, Shigeo
    Shimatsu, Akira
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2013, 169 (02) : 203 - 209
  • [40] Caution is needed when interpreting changes of matrix metalloproteinase-3 in patients with rheumatoid arthritis
    Takao Nagashima
    Seiji Minota
    Rheumatology International, 2014, 34 : 1025 - 1026
12345